- President, International Friends Associations, Rambam Health Care Campus
- Professor Emeritus, The Bruce and Ruth Rappaport Faculty of Medicine, Technion-Israel Institute of Technology
- Chairman of the Steering Committee, the Eyal Ofer Heart Hospital and the Helmsley Health Discovery Tower
- Interventional Cardiologist
Professor Rafael (Rafi) Beyar, is an interventional cardiologist, a biomedical engineer and an innovator, former director of Rambam Health Care Campus, Professor Emeritus of Medicine and Biomedical Engineering at the Technion-IIT, and former Dean of the Technion's Faculty of Medicine. Beyar received an MD from Tel Aviv University, DSc in Biomedical Engineering from the Technion, and MPH from the Bloomberg School of Public Health, Johns Hopkins University. He trained at Rambam and Johns Hopkins Cardiology.
Beyar's research interests were cardiovascular simulations, coronary stents and cardiovascular robotics. He has authored more than 200 publications and 15 books, and is the recipient of numerous awards. He served as the Director of Interventional Cardiology at Rambam (1996–2006) and as Dean of the Rappaport Faculty of Medicine (1999–2004), establishing the Johns Hopkins Technion-Collaboration Program. During his term, Professors Hershko and Chiechanover were awarded the 2004 Nobel Prize in Chemistry. Beyar successfully led the hospital through the 2006 Second Lebanon War, when it was under missile attack. He led development of the hospital’s 2,000-bed Fortified Underground Emergency Hospital, the Children’s Hospital, the Oncology Center, and the Heart Hospital. Since 2018, he has led construction of the Health Discovery Tower, a premiere integrated research and innovation hub is underway, in collaboration with the academia and industry.
Beyar founded the hospital’s technology transfer company, Rambam MedTech Ltd. (2014), and the MindUp Incubator on Digital Health with Rambam, Medtronic, IBM Pitango and Impact first in 2017. Beyar served as chair of the Israeli Basket Committee (2010–2014) and serves as the chair of the Steering Committee for the Israeli Organ Transplant Center since 2010.
Beyar co-founded InStent, which was acquired by Medtronic and NaviCath (later Corindus), a Technion Incubator Company, the first-in-the-world robotic coronary intervention, which was acquired by Siemens Healthineers (2019). He currently serves as director of BioRap of the Rappaport Institute and Rambam Med-Tech and is serving as director or advisor in several start-up companies. He founded and co-chairs with Professor Chaim Lotan the international meeting, Innovation in Cardiovascular Interventions (ICI) since 1996.